Comparative Analytical Evaluation of the Proposed Biosimilar FYB206 and its Reference Medicinal Product Keytruda®

• Autors principals: Jakob C. Stüber (Autor), Kerstin Uhland (Autor), Alwin Reiter (Autor), Steffen Jakob (Autor), Florian Wolschin (Autor)
• Format: Llibre
• Publicat: Adis, Springer Healthcare, 2024-09-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Abstract Background and Objective Biological medicinal products improve patients' lives, but access is limited, mainly due to high costs. Patents for many existing biological products are expiring, and generic versions, which are referred to as biosimilars, are produced to serve as an alternati...